Prognostic Value of Dual-Time-Point ¹⁸F-Fluorodeoxyglucose PET/CT in Metastatic Breast Cancer: An Exploratory Study of Quantitative Measures

• Main Authors: Mohammad Naghavi-Behzad, Charlotte Bjerg Petersen, Marianne Vogsen, Poul-Erik Braad, Malene Grubbe Hildebrandt, Oke Gerke
• Format: Article
• Language: English
• Published: MDPI AG 2020-06-01
• Series: Diagnostics
• Subjects: metastatic breast cancer; FDG-PET/CT; metabolic tumor volume; prognostic value; total lesion glycolysis
• Online Access: https://www.mdpi.com/2075-4418/10/6/398

This study aimed to compare the prognostic value of quantitative measures of [¹⁸F]-fluorodeoxyglucose positron emission tomography with integrated computed tomography (FDG-PET/CT) for the response monitoring of patients with metastatic breast cancer (MBC). In this prospective study, 22 patients with biopsy-verified MBC diagnosed between 2011 and 2014 at Odense University Hospital (Denmark) were followed up until 2019. A dual-time-point FDG-PET/CT scan protocol (1 and 3 h) was applied at baseline, when MBC was diagnosed. Baseline characteristics and quantitative measures of maximum standardized uptake value (SUVmax), mean standardized uptake value (SUVmean), corrected SUVmean (cSUVmean), metabolic tumor volume (MTV), total lesion glycolysis (TLG), and corrected TLG (cTLG) were collected. Survival time was analyzed using the Kaplan–Meier method and was regressed on MTV, TLG, and cTLG while adjusting for clinicopathological characteristics. Among the 22 patients included (median age: 59.5 years), 21 patients (95%) died within the follow-up period. Median survival time was 29.13 months (95% Confidence interval: 20.4–40 months). Multivariable Cox proportional hazards regression analyses of survival time showed no influence from the SUVmean, cSUVmean, or SUVmax, while increased values of MTV, TLG, and cTLG were significantly associated with slightly higher risk, with hazard ratios ranging between 1.0003 and 1.004 (<i>p</i> = 0.007 to <i>p</i> = 0.026). Changes from 1 to 3 h were insignificant for all PET measures in the regression model. In conclusion, MTV and TLG are potential prognostic markers for overall survival in MBC patients.